Key Financial Data Of Reporting Company

COSMOS Pharmaceutical Corporation - Filing #7542519

Concept 2023-06-01 to
2023-08-31
As at
2023-08-31
As at
2023-05-31
2022-06-01 to
2023-05-31
As at
2022-08-31
2022-06-01 to
2022-08-31
Key financial data of reporting company
Business results of reporting company
Net sales
241,653,000,000 JPY
827,697,000,000 JPY
206,122,000,000 JPY
Ordinary profit (loss)
9,699,000,000 JPY
33,086,000,000 JPY
9,626,000,000 JPY
Net assets
215,302,000,000 JPY
211,072,000,000 JPY
195,406,000,000 JPY
Total assets
435,129,000,000 JPY
420,967,000,000 JPY
373,301,000,000 JPY
Basic earnings (loss) per share
164.35
600.96
163.68
Diluted earnings per share
Equity-to-asset ratio
0.495 xbrli:pure
0.501 xbrli:pure
0.523 xbrli:pure

Talk to a Data Expert

Have a question? We'll get back to you promptly.